RS60604A - Carboxamidine derivatives and their use in the treatment of vascular diseases - Google Patents
Carboxamidine derivatives and their use in the treatment of vascular diseasesInfo
- Publication number
- RS60604A RS60604A YU60604A YUP60604A RS60604A RS 60604 A RS60604 A RS 60604A YU 60604 A YU60604 A YU 60604A YU P60604 A YUP60604 A YU P60604A RS 60604 A RS60604 A RS 60604A
- Authority
- RS
- Serbia
- Prior art keywords
- treatment
- vascular diseases
- carboxamidine derivatives
- carboxamidine
- derivatives
- Prior art date
Links
- 208000019553 vascular disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Ovaj pronalazak se odnosi na derivate karboksamidina, na farmaceutske kompozicije koje ih sadrže i na njihovu upotrebu u dobijanju farmaceutskih kompozicija za tretiranje vaskularnih oboljenja.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0200109A HUP0200109D0 (en) | 2002-01-11 | 2002-01-11 | Compounds having pharmaceutical activity |
HU0204362A HUP0204362D0 (en) | 2002-12-17 | 2002-12-17 | Compounds having pharmaceutical activity |
PCT/HU2003/000003 WO2003057664A1 (en) | 2002-01-11 | 2003-01-10 | Carboxamidine derivatives and their use in the treatment of vascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
RS60604A true RS60604A (en) | 2006-12-15 |
Family
ID=90001534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU60604A RS60604A (en) | 2002-01-11 | 2003-01-10 | Carboxamidine derivatives and their use in the treatment of vascular diseases |
Country Status (17)
Country | Link |
---|---|
US (5) | US7384936B2 (sr) |
EP (1) | EP1492763A1 (sr) |
JP (1) | JP2005514418A (sr) |
KR (1) | KR20040089102A (sr) |
CN (1) | CN1615296A (sr) |
AU (1) | AU2003202104B8 (sr) |
BR (1) | BR0306778A (sr) |
CA (1) | CA2471752A1 (sr) |
HR (1) | HRP20040558A2 (sr) |
IL (1) | IL162941A0 (sr) |
MX (1) | MXPA04006716A (sr) |
NO (1) | NO20043029L (sr) |
NZ (1) | NZ533795A (sr) |
PL (1) | PL371251A1 (sr) |
RS (1) | RS60604A (sr) |
RU (1) | RU2320330C2 (sr) |
WO (1) | WO2003057664A1 (sr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057664A1 (en) * | 2002-01-11 | 2003-07-17 | Biorex Kutató És Fejlesztö Rt. | Carboxamidine derivatives and their use in the treatment of vascular diseases |
HUE025852T2 (en) | 2008-06-26 | 2016-04-28 | Orphazyme Aps | Use of HSP70 to regulate enzyme activity |
RU2013125923A (ru) | 2010-11-30 | 2015-01-10 | Орфазиме Апс | СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70 |
PL2892540T3 (pl) * | 2012-09-06 | 2018-12-31 | Mcpharma Biotech Inc. | Leczenie biegunki i biegunki po odsadzeniu przy pomocy opornej skrobi ziemniaczanej |
PL3193840T3 (pl) | 2014-09-15 | 2021-12-06 | Orphazyme A/S | Preparat arimoklomolu |
BR112018070257B1 (pt) | 2016-04-01 | 2022-12-06 | 3M Innovative Properties Company | Dispositivo de proteção auditiva e método de formação do mesmo |
EP3442530A1 (en) | 2016-04-13 | 2019-02-20 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
RS61291B1 (sr) | 2016-04-29 | 2021-02-26 | Orphazyme As | Arimoklomol za lečenje poremećaja povezanih sa glukocerebrozidazom |
MX2023005954A (es) | 2020-11-19 | 2023-09-04 | Zevra Denmark As | Procesos para preparar citrato de arimoclomol e intermediarios del mismo. |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU177578B (en) | 1976-08-27 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
DE2651083A1 (de) * | 1976-11-09 | 1978-05-18 | Hoechst Ag | Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung |
IT1110460B (it) * | 1977-03-02 | 1985-12-23 | Ciba Geigy Ag | Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego |
US4187220A (en) * | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
EP0369944A1 (de) | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
HUT54347A (en) | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
GB9017351D0 (en) | 1990-08-08 | 1990-09-19 | Wellcome Found | Medicaments for treatment of atherosclerosis |
EP0495750A3 (en) | 1991-01-14 | 1992-09-16 | Ciba-Geigy Ag | Heterocyclic hydroxylamine |
US5334600A (en) * | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
WO1995030649A1 (en) * | 1994-05-06 | 1995-11-16 | Biorex Kutató És Fejleszto^' Rt. | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
HU218480B (hu) | 1995-06-15 | 2000-09-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények |
HU9502843D0 (en) | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
UA64716C2 (en) * | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells | |
HU220971B1 (hu) | 1997-04-03 | 2002-07-29 | BIOREX Kutató és Fejlesztő Rt. | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
HUP9702365A3 (en) * | 1997-04-22 | 1999-09-28 | Biorex Kutato Fejlesztoe Kft | Application of hydroxilamin-derivatives, as well as process and composition for increase of weather extreme resistent by cultivated plants |
HU226617B1 (en) | 1998-12-14 | 2009-04-28 | Cytrx Corp | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient |
HUP9900475D0 (en) | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
HUP0001583A2 (hu) * | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
WO2003057664A1 (en) * | 2002-01-11 | 2003-07-17 | Biorex Kutató És Fejlesztö Rt. | Carboxamidine derivatives and their use in the treatment of vascular diseases |
HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
-
2003
- 2003-01-10 WO PCT/HU2003/000003 patent/WO2003057664A1/en active Application Filing
- 2003-01-10 JP JP2003557981A patent/JP2005514418A/ja active Pending
- 2003-01-10 RU RU2004124378/15A patent/RU2320330C2/ru not_active IP Right Cessation
- 2003-01-10 NZ NZ533795A patent/NZ533795A/xx not_active IP Right Cessation
- 2003-01-10 US US10/501,029 patent/US7384936B2/en not_active Expired - Fee Related
- 2003-01-10 MX MXPA04006716A patent/MXPA04006716A/es active IP Right Grant
- 2003-01-10 BR BR0306778-5A patent/BR0306778A/pt not_active IP Right Cessation
- 2003-01-10 AU AU2003202104A patent/AU2003202104B8/en not_active Ceased
- 2003-01-10 EP EP03700962A patent/EP1492763A1/en not_active Withdrawn
- 2003-01-10 CA CA002471752A patent/CA2471752A1/en not_active Abandoned
- 2003-01-10 IL IL16294103A patent/IL162941A0/xx unknown
- 2003-01-10 RS YU60604A patent/RS60604A/sr unknown
- 2003-01-10 CN CNA03802151XA patent/CN1615296A/zh active Pending
- 2003-01-10 KR KR10-2004-7010650A patent/KR20040089102A/ko not_active Application Discontinuation
- 2003-01-10 PL PL03371251A patent/PL371251A1/xx unknown
-
2004
- 2004-06-17 HR HR20040558A patent/HRP20040558A2/hr not_active Application Discontinuation
- 2004-07-12 US US10/889,966 patent/US7361655B2/en not_active Expired - Fee Related
- 2004-07-13 NO NO20043029A patent/NO20043029L/no not_active Application Discontinuation
-
2007
- 2007-10-30 US US11/981,376 patent/US7691849B2/en not_active Expired - Fee Related
- 2007-10-30 US US11/981,422 patent/US7550457B2/en not_active Expired - Fee Related
-
2009
- 2009-06-18 US US12/487,151 patent/US20090253690A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2004124378A (ru) | 2005-04-20 |
JP2005514418A (ja) | 2005-05-19 |
BR0306778A (pt) | 2004-12-28 |
US20090253690A1 (en) | 2009-10-08 |
AU2003202104B2 (en) | 2008-09-18 |
CA2471752A1 (en) | 2003-07-17 |
NO20043029L (no) | 2004-10-11 |
US7691849B2 (en) | 2010-04-06 |
US7384936B2 (en) | 2008-06-10 |
US20050043295A1 (en) | 2005-02-24 |
RU2320330C2 (ru) | 2008-03-27 |
US7361655B2 (en) | 2008-04-22 |
AU2003202104A1 (en) | 2003-07-24 |
US20090075993A1 (en) | 2009-03-19 |
WO2003057664A1 (en) | 2003-07-17 |
EP1492763A1 (en) | 2005-01-05 |
PL371251A1 (en) | 2005-06-13 |
US20060058294A1 (en) | 2006-03-16 |
CN1615296A (zh) | 2005-05-11 |
MXPA04006716A (es) | 2004-11-10 |
IL162941A0 (en) | 2005-11-20 |
KR20040089102A (ko) | 2004-10-20 |
NZ533795A (en) | 2006-03-31 |
AU2003202104B8 (en) | 2008-10-02 |
US7550457B2 (en) | 2009-06-23 |
US20080058323A1 (en) | 2008-03-06 |
HRP20040558A2 (en) | 2004-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY143795A (en) | Tetrahydropyridoindole derivatives | |
MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
HK1057752A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
IL157656A (en) | Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
GEP20063741B (en) | Nonaryl-Heterocyclic NMDA/NR2B Antagonists | |
IL173348A (en) | Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
HUP0400918A3 (en) | Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases | |
IL163831A (en) | Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
PL370111A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
IL175568A (en) | Tyrosine kinase inhibitors, containing them containing herbal remedies and their use in the preparation of a drug for the treatment of diseases | |
TW200514772A (en) | Novel tetrahydropyridine derivatives | |
IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
TW200517107A (en) | Novel formulation | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
IL163951A0 (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same |